Nonsurgical Treatment of Dupuytren's Contracture: 1-Year US Post-Marketing Safety Data for Collagenase Clostridium Histolyticum
- 24 March 2012
- journal article
- research article
- Published by SAGE Publications in HAND
- Vol. 7 (2) , 143-146
Abstract
Background: Collagenase clostridium histolyticum (CCH) is a Food and Drug Administration-approved treatment for adult patients with Dupuytren's contracture with a palpable cord that has been shown efficacious and safe in clinical trials. Methods: This paper summarizes the most common post-marketing clinical adverse event (AE) reports received by the manufacturer of CCH and sponsor of the US Biologics License Application (Auxilium Pharmaceuticals, Malvern, PA, USA) during the first 12 months after drug approval and commercialization in the USA. Results: Of the 115 AE reports describing 270 AEs voluntarily received from patients or health care providers after approximately 5,400 injections of CCH administered, the most common AEs involved local, nonserious reactions to treatment, including skin tears, peripheral edema, and contusion. There were few serious AEs observed (0.6% reporting rate per 1,000 injections), and two flexor tendon ruptures and one flexor pulley injury were reported. Conclusions: Analysis of post-marketing AEs received for CCH in the first year post-approval supports the safety profile reported earlier during clinical development and did not reveal additional clinical risks or concerns about CCH.Keywords
This publication has 13 references indexed in Scilit:
- Flexor Tendon Rupture After Collagenase Injection for Dupuytren Contracture: Case ReportThe Journal of Hand Surgery, 2011
- A Systematic Review of Outcomes of Fasciotomy, Aponeurotomy, and Collagenase Treatments for Dupuytren's ContractureHAND, 2011
- Astley Cooper: His Life and Surgical ContributionsThe Journal of Hand Surgery, 2011
- Injectable Collagenase Clostridium Histolyticum: A New Nonsurgical Treatment for Dupuytren's DiseaseThe Journal of Hand Surgery, 2010
- Collagenase clostridium histolyticum for Dupuytren's contractureExpert Opinion on Biological Therapy, 2010
- Injectable Collagenase Clostridium Histolyticum for Dupuytren's ContractureNew England Journal of Medicine, 2009
- THE CLASSIC: A Treatise on Dislocations and on Fractures of the Joints: Fractures of the Neck of the Thigh-boneClinical Orthopaedics and Related Research, 2007
- Adverse drug event monitoring at the food and drug administrationJournal of General Internal Medicine, 2003
- The early history of contracture of the palmar fascia: Part 2: The revolution in Paris: Guillaume Dupuytren: Dupuytren's diseaseJournal of Hand Surgery (European Volume), 1988
- Limited proteolysis of type I collagen at hyperreactive sites by class I and II Clostridium histolyticum collagenases: complementary digestion patternsBiochemistry, 1987